1-19 of 19
Robert C. Young
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I and Pharmacokinetic Study of Ormaplatin (Tetraplatin, NSC 363812) Administered on a Day 1 and Day 8 Schedule

Russell J. Schilder, Frank P. LaCreta, Raymond P. Perez, Steven W. Johnson, James M. Brennan, Andre Rogatko, Sherri Nash, Ceclia McAleer, Thomas C. Hamilton, David Roby, Robert C. Young, Robert F. Ozols, Peter J. O'Dwyer
Journal: Cancer Research
Cancer Res (1994) 54 (3): 709–717.
Published: 01 February 1994
View article titled, Phase I and Pharmacokinetic Study of Ormaplatin (Tetraplatin, NSC 363812) Administered on a Day 1 and Day 8 Schedule
Open the PDF for Phase I and Pharmacokinetic Study of Ormaplatin (Tetraplatin, NSC 363812) Administered on a Day 1 and Day 8 Schedule in another window
Journal Articles

Evaluation of Platinum-DNA Adduct Levels Relative to Known Prognostic Variables in a Cohort of Ovarian Cancer Patients

Eddie Reed, Yechiam Ostchega, Seth M. Steinberg, Stuart H. Yuspa, Robert C. Young, Robert F. Ozols, Miriam C. Poirier
Journal: Cancer Research
Cancer Res (1990) 50 (8): 2256–2260.
Published: 01 April 1990
View article titled, Evaluation of Platinum-DNA Adduct Levels Relative to Known Prognostic Variables in a Cohort of Ovarian Cancer Patients
Open the PDF for Evaluation of Platinum-DNA Adduct Levels Relative to Known Prognostic Variables in a Cohort of Ovarian Cancer Patients in another window
Journal Articles

Characterization of a cis-Diamminedichloroplatinum(II)-resistant Human Ovarian Cancer Cell Line and Its Use in Evaluation of Platinum Analogues

Brent C. Behrens, Thomas C. Hamilton, Hidetaka Masuda, Karen R. Grotzinger, Jacqueline Whang-Peng, Karen G. Louie, Turid Knutsen, Wilma M. McKoy, Robert C. Young, Robert F. Ozols
Journal: Cancer Research
Cancer Res (1987) 47 (2): 414–418.
Published: 01 January 1987
View article titled, Characterization of a <em>cis</em>-Diamminedichloroplatinum(II)-resistant Human Ovarian Cancer Cell Line and Its Use in Evaluation of Platinum Analogues
Open the PDF for Characterization of a <em>cis</em>-Diamminedichloroplatinum(II)-resistant Human Ovarian Cancer Cell Line and Its Use in Evaluation of Platinum Analogues in another window
Journal Articles

Characterization of a Xenograft Model of Human Ovarian Carcinoma Which Produces Ascites and Intraabdominal Carcinomatosis in Mice

Thomas C. Hamilton, Robert C. Young, Karen G. Louie, Brent C. Behrens, Wilma M. McKoy, Karen R. Grotzinger, Robert F. Ozols
Journal: Cancer Research
Cancer Res (1984) 44 (11): 5286–5290.
Published: 01 November 1984
View article titled, Characterization of a Xenograft Model of Human Ovarian Carcinoma Which Produces Ascites and Intraabdominal Carcinomatosis in Mice
Open the PDF for Characterization of a Xenograft Model of Human Ovarian Carcinoma Which Produces Ascites and Intraabdominal Carcinomatosis in Mice in another window
Journal Articles

Phase II and Pharmacokinetic Study of Aziridinylbenzoquinone [2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, Diaziquone, NSC 182986] in High-Grade Gliomas

Gregory A. Curt, James A. Kelley, Conrad V. Kufta, Barry H. Smith, Paul L. Komblith, Robert C. Young, Jerry M. Collins
Journal: Cancer Research
Cancer Res (1983) 43 (12_Part_1): 6102–6105.
Published: 01 December 1983
View article titled, Phase II and Pharmacokinetic Study of Aziridinylbenzoquinone [2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, Diaziquone, NSC 182986] in High-Grade Gliomas
Open the PDF for Phase II and Pharmacokinetic Study of Aziridinylbenzoquinone [2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, Diaziquone, NSC 182986] in High-Grade Gliomas in another window
Journal Articles

Characterization of a Human Ovarian Carcinoma Cell Line (NIH:OVCAR-3) with Androgen and Estrogen Receptors

Thomas C. Hamilton, Robert C. Young, Wilma M. McKoy, Karen R. Grotzinger, John A. Green, Elizabeth W. Chu, Jacqueline Whang-Peng, Alfred M. Rogan, William R. Green, Robert F. Ozols
Journal: Cancer Research
Cancer Res (1983) 43 (11): 5379–5389.
Published: 01 November 1983
View article titled, Characterization of a Human Ovarian Carcinoma Cell Line (NIH:OVCAR-3) with Androgen and Estrogen Receptors
Open the PDF for Characterization of a Human Ovarian Carcinoma Cell Line (NIH:OVCAR-3) with Androgen and Estrogen Receptors in another window
Journal Articles

Evidence of a Treatment Dose Response in Acute Nonlymphocytic Leukemias Which Occur after Therapy of Non-Hodgkin's Lymphoma

Mark H. Greene, Robert C. Young, John M. Merrill, Vincent T. DeVita
Journal: Cancer Research
Cancer Res (1983) 43 (4): 1891–1898.
Published: 01 April 1983
View article titled, Evidence of a Treatment Dose Response in Acute Nonlymphocytic Leukemias Which Occur after Therapy of Non-Hodgkin's Lymphoma
Open the PDF for Evidence of a Treatment Dose Response in Acute Nonlymphocytic Leukemias Which Occur after Therapy of Non-Hodgkin's Lymphoma in another window
Journal Articles

Effects of Amphotericin B on Adriamycin and Melphalan Cytotoxicity in Human and Murine Ovarian Carcinoma and in L1210 Leukemia

Robert F. Ozols, W. Michael Hogan, Karen R. Grotzinger, Wilma McCoy, Robert C. Young
Journal: Cancer Research
Cancer Res (1983) 43 (3): 959–964.
Published: 01 March 1983
View article titled, Effects of Amphotericin B on Adriamycin and Melphalan Cytotoxicity in Human and Murine Ovarian Carcinoma and in L1210 Leukemia
Open the PDF for Effects of Amphotericin B on Adriamycin and Melphalan Cytotoxicity in Human and Murine Ovarian Carcinoma and in L1210 Leukemia in another window
Journal Articles

Phase I and Pharmacological Studies of Adriamycin Administered Intraperitoneally to Patients with Ovarian Cancer

Robert F. Ozols, Robert C. Young, James L. Speyer, Paul H. Sugarbaker, Raymond Greene, Jean Jenkins, Charles E. Myers
Journal: Cancer Research
Cancer Res (1982) 42 (10): 4265–4269.
Published: 01 October 1982
View article titled, Phase I and Pharmacological Studies of Adriamycin Administered Intraperitoneally to Patients with Ovarian Cancer
Open the PDF for Phase I and Pharmacological Studies of Adriamycin Administered Intraperitoneally to Patients with Ovarian Cancer in another window
Journal Articles

Phase I Trial and Pharmacokinetics of Aziridinylbenzoquinone (NSC 182986) in Humans

Richard L. Schilsky, James A. Kelley, Daniel C. Ihde, Dianne M. Howser, Rosemarie S. Cordes, Robert C. Young
Journal: Cancer Research
Cancer Res (1982) 42 (4): 1582–1586.
Published: 01 April 1982
View article titled, Phase I Trial and Pharmacokinetics of Aziridinylbenzoquinone (NSC 182986) in Humans
Open the PDF for Phase I Trial and Pharmacokinetics of Aziridinylbenzoquinone (NSC 182986) in Humans in another window
Journal Articles

Inhibition of Human Ovarian Cancer Colony Formation by Adriamycin and Its Major Metabolites

Robert F. Ozols, James K. V. Willson, Martin D. Weltz, Karen R. Grotzinger, Charles E. Myers, Robert C. Young
Journal: Cancer Research
Cancer Res (1980) 40 (11): 4109–4112.
Published: 01 November 1980
View article titled, Inhibition of Human Ovarian Cancer Colony Formation by Adriamycin and Its Major Metabolites
Open the PDF for Inhibition of Human Ovarian Cancer Colony Formation by Adriamycin and Its Major Metabolites in another window
Journal Articles

Cloning of Human Ovarian Cancer Cells in Soft Agar from Malignant Effusions and Peritoneal Washings

Robert F. Ozols, James K. V. Willson, Karen R. Grotzinger, Robert C. Young
Journal: Cancer Research
Cancer Res (1980) 40 (8_Part_1): 2743–2747.
Published: 01 August 1980
View article titled, Cloning of Human Ovarian Cancer Cells in Soft Agar from Malignant Effusions and Peritoneal Washings
Open the PDF for Cloning of Human Ovarian Cancer Cells in Soft Agar from Malignant Effusions and Peritoneal Washings in another window
Journal Articles

Pharmacokinetics of Adriamycin and Tissue Penetration in Murine Ovarian Cancer

Robert F. Ozols, Gershon Y. Locker, James H. Doroshow, Karen R. Grotzinger, Charles E. Myers, Robert C. Young
Journal: Cancer Research
Cancer Res (1979) 39 (8): 3209–3214.
Published: 01 August 1979
View article titled, Pharmacokinetics of Adriamycin and Tissue Penetration in Murine Ovarian Cancer
Open the PDF for Pharmacokinetics of Adriamycin and Tissue Penetration in Murine Ovarian Cancer in another window
Journal Articles

Kinetic Characterization and Response to Chemotherapy in a Transplantable Murine Ovarian Cancer

Robert F. Ozols, Karen R. Grotzinger, Richard I. Fisher, Charles E. Myers, Robert C. Young
Journal: Cancer Research
Cancer Res (1979) 39 (8): 3202–3208.
Published: 01 August 1979
View article titled, Kinetic Characterization and Response to Chemotherapy in a Transplantable Murine Ovarian Cancer
Open the PDF for Kinetic Characterization and Response to Chemotherapy in a Transplantable Murine Ovarian Cancer in another window
Journal Articles

Kinetic Alterations Induced by 5-Fluorouracil in Bone Marrow, Intestinal Mucosa, and Tumor

Charles E. Myers, Robert C. Young, Bruce A. Chabner
Journal: Cancer Research
Cancer Res (1976) 36 (5): 1653–1658.
Published: 01 May 1976
View article titled, Kinetic Alterations Induced by 5-Fluorouracil in Bone Marrow, Intestinal Mucosa, and Tumor
Open the PDF for Kinetic Alterations Induced by 5-Fluorouracil in Bone Marrow, Intestinal Mucosa, and Tumor in another window
Journal Articles

Inhibition and Recovery of DNA Synthesis in Host Tissues and Sensitive and Resistant B16 Melanoma after 1-(2-Chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea, a Predictor of Therapeutic Efficacy

Harmar D. Brereton, Thomas L. Bryant, Robert C. Young
Journal: Cancer Research
Cancer Res (1975) 35 (9): 2420–2425.
Published: 01 September 1975
View article titled, Inhibition and Recovery of DNA Synthesis in Host Tissues and Sensitive and Resistant B16 Melanoma after 1-(2-Chloroethyl)-3-(<em>trans</em>-4-methylcyclohexyl)-1-nitrosourea, a Predictor of Therapeutic Efficacy
Open the PDF for Inhibition and Recovery of DNA Synthesis in Host Tissues and Sensitive and Resistant B16 Melanoma after 1-(2-Chloroethyl)-3-(<em>trans</em>-4-methylcyclohexyl)-1-nitrosourea, a Predictor of Therapeutic Efficacy in another window
Journal Articles

Assay of 5-Fluorodeoxyuridine 5′-Monophosphate and Deoxyuridine 5′-Monophosphate Pools following 5-Fluorouracil

Charles E. Myers, Robert C. Young, David G. Johns, Bruce A. Chabner
Journal: Cancer Research
Cancer Res (1974) 34 (10): 2682–2688.
Published: 01 October 1974
View article titled, Assay of 5-Fluorodeoxyuridine 5′-Monophosphate and Deoxyuridine 5′-Monophosphate Pools following 5-Fluorouracil
Open the PDF for Assay of 5-Fluorodeoxyuridine 5′-Monophosphate and Deoxyuridine 5′-Monophosphate Pools following 5-Fluorouracil in another window
Journal Articles

The Effect of Chemotherapy on the Growth Characteristics and Cellular Kinetics of Leukemia L1210

Robert C. Young, Vincent T. DeVita
Journal: Cancer Research
Cancer Res (1970) 30 (6): 1789–1794.
Published: 01 June 1970
View article titled, The Effect of Chemotherapy on the Growth Characteristics and Cellular Kinetics of Leukemia L1210
Open the PDF for The Effect of Chemotherapy on the Growth Characteristics and Cellular Kinetics of Leukemia L1210 in another window
Journal Articles

The Thymidine-14C and -3H Double-labeling Technic in the Study of the Cell Cycle of L1210 Leukemia Ascites Tumor in Vivo

Robert C. Young, Vincent T. DeVita, Seymour Perry
Journal: Cancer Research
Cancer Res (1969) 29 (8): 1581–1584.
Published: 01 August 1969
View article titled, The Thymidine-<sup>14</sup>C and -<sup>3</sup>H Double-labeling Technic in the Study of the Cell Cycle of L1210 Leukemia Ascites Tumor <em>in Vivo</em>
Open the PDF for The Thymidine-<sup>14</sup>C and -<sup>3</sup>H Double-labeling Technic in the Study of the Cell Cycle of L1210 Leukemia Ascites Tumor <em>in Vivo</em> in another window